Weight gain is a major problem that faces physicians striving to achieve adequate glycemic, blood pressure and lipid control for their diabetic patients. The use of antidiabetic agents, particularly insulin, insulin secretagogs and thiazolidinediones, has long been associated with weight gain, not ...
Understanding body weight regulation in type 2 diabetic patients is therefore necessary to better adapt for the effect of such medication on weight. Expressed in terms of energy, weight gain results from positive energy balance. Positive energy balance in type 2 diabetes is most usually a...
Weight gain is a major problem that faces physicians striving to achieve adequate glycemic, blood pressure and lipid control for their diabetic patients. The use of antidiabetic agents, particularly insulin, insulin secretagogs and thiazolidinediones, has long been associated with weight gain, not ...
摘要: Focuses on a study which tested the hypothesis that insulin-treated type 2 diabetic patients might return to the maximal weight they reached before the onset of diabetes- and insulin deficiency-induced weight loss. Methodology; Results; Interpretation of findings....
is the cornerstone of glycemic control in the patient with type 1 diabetes.(3) Most of what we know regarding the benefits of intensive insulin therapy is derived from the Diabetes Control and Complications Trial (DCCT), a trial of patients with type 1 diabetes who were randomized to either ...
In this retrospective study, we tested the hypothesis that the weight gain in a diabetic population is greater than that in the general population. RESEARCH DESIGN AND METHODS -- Data were obtained from the records of 205 adult men who have attended a diabetes clinic for ≥5 years. Their ...
The Institute of Medicine updated guidelines for gestational weight gain in 2009, with no special recommendations for gestational diabetes. Our objectives were to describe the prevalence of weight gain adequacy and their association with adverse pregnancy outcomes in gestational diabetes. We searched MEDLIN...
The purpose of this study was to evaluate the metabolic control of the type I diabetic patients seen from 1984 to 1988. We analyzed the results of HbA1, height velocity and weight gain. Results showed that from 1984 1985 a 90% of diabetics were in poor metabolic control with HbA1 > 11...
For eligible patients, this medicine is given as a subcutaneous (under the skin) injection once a day (in the abdomen, thigh, or upper arm). It comes as a prefilled injection pen and you (or a caregiver) can learn to self-inject this medicine so you can administer it at home....
Effect of caloric restriction on energy expenditure in obese patients. Lancet. 1969;2(7617):397-398. doi:10.1016/S0140-6736(69)90109-3 PubMedGoogle ScholarCrossref 32. Russell-Jones D, Khan R. Insulin-associated weight gain in diabetes—causes, effects and coping strategies....